A UCLA-led study on a two-drug therapy combining injectable naltrexone and extended-release bupropion showed significant reductions in methamphetamine use among participants up to 12 weeks into treatment.
Research from
Categories
UCLA’s Dual Drug Therapy Proves Effective in Clinical Trials
